CAHP Statement: PhRMA SB 17 Litigation
As part of its usual obstructionist playbook, the Pharmaceutical Research and Manufacturers of America (PhRMA) today filed a lawsuit challenging California’s recently-passed drug pricing transparency law, SB 17.
CAHP Statement: CAHP Issues Statement on State Assembly’s Universal Health Care Hearings
Today, California Association of Health Plans President and CEO Charles Bacchi released the following statement regarding the State Assembly Select Committee on Health Care Delivery Systems and Universal Coverage Hearings that took place on October 23 and 24.
CAHP Statement: Trump Administration’s Decision to End CSR Benefits for Low-To-Middle Income Individuals and Families
California Association of Health Plans President and CEO Charles Bacchi released the following statement today regarding the Trump administration's decision to end cost sharing reduction (CSR) benefits.
CAHP Statement: 2018 Covered California Rate Release
Covered California today announced the final rates for its health plans in 2018 noting that, in the absence of a federal commitment to fund cost-sharing reduction (CSR) reimbursements for the upcoming year, it will be adding an average surcharge of 12.4 percent to Silver-tier plans in 2018. The surcharge will only be applied to Silver-tier plans and, as such, most enrollees' premiums will not be affected by the surcharge.
CAHP Statement: CAHP Applauds Governor Brown’s Signing of Landmark Prescription Drug Price Transparency Bill into Law
The California Association of Health Plans today applauded California Governor Jerry Brown’s signing of the groundbreaking SB 17 (Hernandez) into law. This pivotal moment marks a major victory for patients, healthcare providers and local governments alike in the battle to rein in spiraling prescription drug prices. The Governor’s signature on the bill comes after several years of united efforts from a broad coalition of health plans, labor unions, patient advocacy groups, business organizations and dozens of others, with two similarly-targeted efforts stalling in the legislature in 2015 and 2016.
CAHP Statement: CAHP Urges Congress to Oppose Graham-Cassidy-Heller-Johnson Proposal
The California Association of Health Plans today sent a letter to the California congressional delegation opposing the Graham-Cassidy-Heller-Johnson proposal, which makes major changes to the Affordable Care Act that will result in adverse consequences for Californians and people across the country.
CAHP Statement: Senate Approves SB 17, Sends Crucial Rx Transparency Bill to Governor’s Desk for Final Consideration
The California State Senate minutes ago joined the Assembly in voting to advance SB 17 (Hernandez), marking a crucial milestone that will advance the prescription drug price transparency bill to the Governor’s desk. The Senate advanced the bill on a 31-8 vote, a strong showing of support that comes on the heels of the Assembly’s overwhelming 66-9 bipartisan vote to advance the bill on Monday.
CAHP Statement: Assembly Passes SB 17 Marking Major Milestone for Fight to Bring Drug Price Transparency to California
The California State Assembly moments ago passed SB 17 (Hernandez) on a bipartisan 66 – 9 vote, sending the bill to the Senate floor for concurrence before moving on to the Governor’s desk. With today’s passage through the Assembly, California moves closer than ever to holding pharmaceutical companies accountable and reining in arbitrary drug price hikes that harm California families.
CAHP Statement: 2018 Covered California Rates
Covered California today announced health insurance rates for 2018, citing an average weighted statewide rate change of 12.5% as the exchange moves into its fifth year of operation. The rates reflect the ongoing uncertainty at the federal level over the future of the Affordable Care Act (ACA) as well as increased spending on medical care and several other factors.
CAHP Statement: CA Assembly Health Committee Advances Crucial Drug Price Transparency Bill
The California Assembly Health Committee today voted to advance SB 17 (Hernandez), marking a crucial milestone in the fight to rein in out-of-control prescription drug pricing. The bill now heads to the California Assembly Appropriations Committee where it will be up for a vote in August.
CAHP Fact Sheet: 5 Ways Health Plans are Supporting California's Hospitals